This products is free for those who attended FNCE® 2019.
If food is medicine, then following a low FODMAP diet should be on every gastroenterologist's prescription pad. Developed in 2005, the low FODMAP diet provided irritable bowel syndrome sufferers the protocol they needed to identify dietary triggers that lead to uncomfortable gas, bloating and gastrointestinal (GI) distress. An acronym for Fermentable Oligo-, Di-, Monosaccharides And Polyols, FODMAP has revolutionized treatment for irritable bowel syndrome (IBS), where previous pharmaceutical interventions provided little to no relief. The father of FODMAP, Dr. Peter Gibson, will explain the research behind the dietary protocol and explain how FODMAP is a short-term diet that informs and allows IBS sufferers to enjoy most foods, within certain limits. Dr. Anne Lee, RDN will discuss her clinical experiences with patients on a low-FODMAP diet protocol, the important role of the RDN in the re-introductory and personalization phase of the diet, and the difference in outcomes between that and traditional pharmaceutical treatments.
CPE Level: 2 - Intermediate
Learning Need Codes: 2020, 3005, 5220
- 10.2.8 Establishes the plan of care, directly addressing the nutrition diagnosis in collaboration with the patient in defining the time, frequency and duration of the intervention.
- 8.1.1 Interprets and applies evidence-based comparative standards for determining nutritional needs.
- 8.3.6 Keeps abreast of current nutrition and dietetics knowledge and trends.
- Identify what a low-FODMAP diet entails and the protocol one would follow.
- Cite established and emerging research on the science-backed benefits of the low FODMAP approach for treating and managing IBS.
- Advocate for the role of the dietitian as the first line of treatment for patients with IBS.
- Anne Lee, EdD, RDN, LD
- Peter Gibson, MD